JP2011504099A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504099A5
JP2011504099A5 JP2010532633A JP2010532633A JP2011504099A5 JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5 JP 2010532633 A JP2010532633 A JP 2010532633A JP 2010532633 A JP2010532633 A JP 2010532633A JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5
Authority
JP
Japan
Prior art keywords
antibody
sequence
monoclonal antibody
sialylated
neu5gc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010532633A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504099A (ja
Filing date
Publication date
Priority claimed from FI20070853A external-priority patent/FI20070853A0/fi
Application filed filed Critical
Publication of JP2011504099A publication Critical patent/JP2011504099A/ja
Publication of JP2011504099A5 publication Critical patent/JP2011504099A5/ja
Pending legal-status Critical Current

Links

JP2010532633A 2007-11-09 2008-11-10 シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法 Pending JP2011504099A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20070853A FI20070853A0 (fi) 2007-11-09 2007-11-09 Glykaania sitovat monoklonaaliset vasta-aineet
PCT/FI2008/050643 WO2009060129A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes

Publications (2)

Publication Number Publication Date
JP2011504099A JP2011504099A (ja) 2011-02-03
JP2011504099A5 true JP2011504099A5 (enExample) 2011-12-22

Family

ID=38786638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532633A Pending JP2011504099A (ja) 2007-11-09 2008-11-10 シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法

Country Status (7)

Country Link
US (1) US20100292095A1 (enExample)
EP (1) EP2209809A4 (enExample)
JP (1) JP2011504099A (enExample)
AU (1) AU2008324073A1 (enExample)
CA (1) CA2743032A1 (enExample)
FI (1) FI20070853A0 (enExample)
WO (1) WO2009060129A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095418A0 (fi) * 2009-04-16 2009-04-16 Suomen Punainen Risti Veripalv Kryptinen subpopulaatio
EP2345964A4 (en) * 2008-10-13 2013-11-20 Mitsubishi Electric Corp CONTRACTING APPROACH, OPERATING PROGRAM, RECORDING MEDIUM AND CONTRACTING PROCESS
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
LT2928476T (lt) 2012-12-07 2018-05-25 Glycomimetics, Inc. Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
US20170306046A1 (en) 2014-11-12 2017-10-26 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
CN108350077A (zh) * 2015-11-03 2018-07-31 糖模拟物有限公司 产生单克隆抗体、造血干细胞的方法和组合物以及利用所述抗体和造血干细胞的方法
CN108463248B (zh) 2015-11-12 2022-10-21 西雅图基因公司 聚糖相互作用化合物及使用方法
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
CA3037850A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
EP3541847A4 (en) 2016-11-17 2020-07-08 Seattle Genetics, Inc. COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
GB201703212D0 (en) * 2017-02-28 2017-04-12 Nat Univ Ireland Galway The detectionm quantification and discrimination of the sialic acid N-glycolylneuraminic (Neu5Gc) acid and N-acetylneuraminic acid (Neu5gc)
EP3589319A4 (en) 2017-03-03 2021-07-14 Seagen Inc. GLYCAN INTERACTING COMPOUNDS AND METHOD OF USE
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
EP3732186A1 (en) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
PT110526B (pt) 2018-01-26 2021-02-04 Univ Nova De Lisboa Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
EP3849605A4 (en) * 2018-09-10 2022-06-15 Cold Spring Harbor Laboratory METHODS OF TREATMENT OF PANCREATITIS
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4965198A (en) * 1985-12-24 1990-10-23 Konica Corporation Monoclonal antibody and method of manufacturing hybridoma producing the same
US4949778A (en) * 1987-12-16 1990-08-21 Kawasaki Steel Corporation Immersion nozzle for continuous casting
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
US7682794B2 (en) * 2003-07-15 2010-03-23 The Regents Of The University Of California Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
FI20055398A0 (fi) * 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
WO2007054622A1 (en) * 2005-11-08 2007-05-18 Suomen Punainen Risti, Veripalvelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
AU2007264846A1 (en) * 2006-06-29 2008-01-03 Glykos Finland Oy Novel cellular glycan compositions
WO2008087258A1 (en) * 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel carbohydrate from human cells and methods for analysis and modification thereof
AU2008206887B9 (en) * 2007-01-18 2011-07-07 Glykos Finland Oy Novel specific cell binders
US20100145032A1 (en) * 2007-01-18 2010-06-10 Suomen Punainen Risti, Veripalelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof

Similar Documents

Publication Publication Date Title
Saeed et al. Antibody engineering for pursuing a healthier future
JP2011504099A (ja) シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法
Linman et al. Surface plasmon resonance study of protein− carbohydrate interactions using biotinylated sialosides
HRP20250850T1 (hr) Antitijela protiv claudina 18.2 korisna u dijagnozi raka
JP2009533021A5 (enExample)
WO2013054331A8 (en) Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
NZ717429A (en) Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102703453A (zh) 特异性识别链霉素的dna适配体及其应用
RU2013142334A (ru) КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а
WO2005010485A3 (en) Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
MX2025004565A (es) Anticuerpos anti-cd3 dependientes de ph y metodos relacionados con estos
US20210017564A1 (en) Antigen treatment method
EP3273241B1 (en) Method and kit for detecting stem cell
RU2009124225A (ru) Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis
CA3115887A1 (en) Antibodies specific for glycosylated apoj and uses thereof
US20110045497A1 (en) Novel acidic glycan markers of human cells
US8043852B2 (en) Monoclonal antibody specific to dentin-derived heparan sulfate
JP2024513880A (ja) 免疫組織化学法およびkir3dl2特異的薬剤
JP5711877B2 (ja) 癌の悪性度の検知方法及び癌の悪性度の診断剤
ATE476449T1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
EA201490286A1 (ru) Моноклональные антитела, специфичные в отношении x-37 бета-амилоида, и пути их применения
JP2020162572A (ja) 抗原の処理方法。
WO2024015522A1 (en) Methods for analyzing extracellular vesicles and microbes
Miyamoto et al. Inhibition of Prion Propagation in Scrapie-infected Cell Lines using Mouse Monoclonal Antibodies against Prion Protein